opioids

Study: Formularies may be key to alleviating opioid epidemicNew Yale University research offers stunning findings about drug formulary coverage and prescribing opioids.
Five ways health executives can impact the opioid crisisConsider these five opportunities to help curb one of the biggest public health issues of the year.
Two opioid use disorder drug developments to watchNew physician-administered therapies on the horizon may help rein in the opioid epidemic.
FDA alters stance on opioid addiction drugs
FDA alters stance on opioid addiction drugsFDA is advising that these 2 opioid addiction medications should not be withheld from patients taking benzodiazepines or other drugs that depress the central nervous system.
Opioids: The menace in our midstOpioids have impacted every population served by all healthcare providers in the United States and by now every nurse practitioner (NP) has been exposed to the opioid scourge. Perhaps it’s time to reassess the role for NPs in caring for their individual populations confronting an opioid crisis.
The opioid pain reliever epidemicThe aim of this article is to educate ob/gyns about what not to do for acute and chronic pain, in the hope that increased awareness will help us prevent suffering and loss of life from opioid pain relievers.
New Cigna program aims to ‘unlock’ the value of healthcare dataCigna publication project takes a page out of the big pharma and medical technology playbook.
Seven things to know about Express Scripts’ plan to limit opioidsAs President Trump declares the opioid epidemic “a national emergency,” a new opioid management program from Express Scripts will limit the number and strength of opioid drugs to first-time patients.
FDA eyes opioids in kids' medicines
FDA eyes opioids in kids' medicinesAn FDA committee will review prescription opioid products containing hydrocodone or codeine to treat coughs in children.
How Cigna reduced opioid use 12% in 12 monthsManaged Healthcare Executive (MHE) recently spoke with Cigna’s Chief Medical Officer for Behavioral Health Doug Nemecek, MD, about Cigna’s efforts, outcomes, and how it plans to reach its goal